Gatekeepers in White Coats: How Medical Boards Have Turned Healthcare Into a Closed Shop

When Americans complain about healthcare costs, the conversation almost invariably turns to insurance companies, pharmaceutical pricing, or hospital billing departments. These are legitimate grievances, but they obscure a more fundamental problem — one that sits at the very entrance to the system rather than inside it. Before a single prescription is written or a single procedure is scheduled, a formidable network of occupational gatekeepers has already ensured that the supply of qualified care is kept artificially and deliberately scarce.

The architects of this scarcity are not shadowy monopolists operating outside the law. They operate entirely within it. They are state medical boards, professional associations, and the legislators who reliably do their bidding. Together, they have constructed a regulatory fortress that limits who may practice medicine, what tasks each practitioner is permitted to perform, and — in dozens of states — how many medical facilities may even exist. The result is a healthcare market that behaves less like a free enterprise system and more like a medieval guild: entry is restricted, competition is suppressed, and prices reflect political power rather than economic reality.

The Credential Bottleneck

Becoming a licensed physician in the United States requires, at minimum, four years of undergraduate education, four years of medical school, and between three and seven years of residency training. None of this is inherently unreasonable for the most complex medical procedures. But the same credential is required to perform tasks that, in virtually every other developed nation, are routinely and safely delegated to nurse practitioners, physician assistants, pharmacists, or other allied health professionals.

Consider the nurse practitioner. Holding a graduate-level degree, thousands of clinical hours, and national board certification, a nurse practitioner is fully capable of diagnosing and treating a wide range of common conditions — yet in many states, they are legally prohibited from doing so without a physician's supervision or a formal collaborative agreement. That agreement, which often requires a supervising physician to sign off on the arrangement, effectively gives incumbent practitioners veto power over new competition. Unsurprisingly, many choose to exercise it.

The research on outcomes in states that have granted nurse practitioners full practice authority is instructive. Studies consistently show no meaningful degradation in patient outcomes and, in many rural and underserved communities, a measurable improvement in access to care. The opposition to full practice authority is not grounded in patient safety data — it is grounded in the economic self-interest of those who benefit from restricted supply.

Certificate-of-Need Laws: Government-Sanctioned Market Rigging

If scope-of-practice restrictions control who may provide care, certificate-of-need (CON) laws control where care may be provided — and in some cases, whether it may be provided at all. Currently on the books in roughly 35 states, CON laws require healthcare providers to obtain government permission before opening a new facility, purchasing major medical equipment, or expanding existing services. The stated rationale is preventing "unnecessary duplication" of healthcare resources.

The actual effect is something far less benign. Under most CON frameworks, existing providers have formal standing to challenge a competitor's application — meaning that a hospital system seeking to block a new surgical center from opening in its market can do so through a bureaucratic process that is costly, time-consuming, and often decisive. This is not a theoretical concern. The Federal Trade Commission and the Department of Justice have jointly criticized CON laws on precisely these grounds, noting that they "can prevent the efficient functioning of health care markets" and "may harm patients."

States without CON laws tend to have more healthcare providers, shorter wait times, and lower costs for many services. The empirical case against these laws is robust. The political case for them — sustained by the lobbying power of incumbent hospital networks — is considerably less principled.

What Other Countries Actually Do

Proponents of America's restrictive licensing regime often invoke the specter of unqualified practitioners and degraded care. What they rarely acknowledge is that many countries with superior healthcare outcomes by standard metrics operate with far more flexible and tiered systems of provider authorization.

In the United Kingdom, pharmacists are empowered to prescribe a broad range of medications independently. In Canada and Australia, nurse practitioners operate with significant autonomy, filling critical gaps in rural and remote communities. In New Zealand, a robust allied health sector handles enormous volumes of primary care without the physician-centric bottleneck that characterizes the American model. None of these nations are experiencing the epidemics of misdiagnosis and malpractice that American medical boards warn against whenever deregulation is proposed.

The United States, meanwhile, spends more per capita on healthcare than any other nation on earth and achieves middling outcomes by nearly every comparative measure. If the licensing cartel's primary justification is quality assurance, the evidence suggests it is failing on its own terms.

The Reform Agenda

A genuinely free-market approach to healthcare access would begin with several concrete reforms that do not require dismantling the entire regulatory apparatus — merely opening the doors that have been welded shut by incumbent interests.

Full practice authority for advanced practice providers. Every state should recognize the full scope of competence that nurse practitioners, physician assistants, and certified nurse-midwives have demonstrated. Supervision requirements that exist solely to protect physician market share should be eliminated.

Repeal of certificate-of-need laws. There is no compelling public interest argument for allowing existing hospital systems to veto competitors. These laws should be repealed at the state level, and Congress should consider conditioning federal healthcare funding on their elimination.

Interstate licensing compacts and reciprocity. A physician licensed in Texas should not face a multi-year credentialing odyssey to practice in Ohio. Expanding interstate compacts and creating genuine reciprocity would dramatically increase the effective supply of practitioners, particularly through telemedicine.

Expanded scope for pharmacists and allied health professionals. Allowing pharmacists to prescribe and administer a broader range of medications and vaccinations — as many states have already done with considerable success — represents one of the lowest-cost, highest-impact reforms available.

The Market the Cartel Fears

The most telling indicator of how artificial these restrictions are is the reaction they provoke. When states have moved toward full practice authority for nurse practitioners, medical associations have not primarily argued that patients will be harmed. They have argued, with remarkable candor, that physician incomes will fall. When certificate-of-need reforms are proposed, incumbent hospital networks do not warn of quality degradation — they warn of "market disruption."

They are correct that markets would be disrupted. That is precisely the point. Markets that function properly disrupt the comfortable arrangements of those who have learned to profit from scarcity. In healthcare, as in every other sector of the economy, competition drives quality up and prices down. The licensing cartel's greatest fear is not an unsafe patient — it is an empowered one.

America will not solve its healthcare cost crisis by tinkering with insurance mandates or negotiating drug prices while leaving the supply-side architecture of restriction entirely intact. Genuine reform begins with recognizing that the gatekeepers in white coats are not merely protecting standards. In many cases, they are protecting market share — and they are doing it with the full force of law.